Characterization of glucokinase polymorphisms associated with Maturity-Onset Diabetes of the Young (MODY2) in Jordanian population

被引:0
|
作者
Fawzu Al-Sheyab
Emran Khamaiseh
Marwan Abu Halaweh
Raida W. Khalil
机构
[1] Jordan University of Science and Technology,Genetic Engineering and Biotechnology Department
[2] Philadelphia University,Biotechnology and Genetic Engineering Department
来源
Cytology and Genetics | 2009年 / 43卷
关键词
Fast Blood Sugar; Normal Control Subject; Restriction Endonu; Polymerase Chain Reaction Product Size; Glucokinase Mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Maturity-Onset Diabetes of the Young (MODY) is a monogenic form of Diabetes Mellitus (DM) characterized by an autosomal dominant inheritance, onset usually before 25 years of age and a primary defect in glucose-stimulated insulin secretion, Glucokinase (GCK) acts as a glucose sensor in the pancreatic beta cell and regulates insulin secretion. The mutation in the gene encoding GCK results in enzyme inactivation cause MODY2. Functional studies of naturally occurring GCK mutations associated with hyperglycaemia provide further insight into the biochemical basis of glucose sensor regulation. In this study 100 diabetic Jordanian patients with MODY2 phenotype and 150 Normal control subjects were screened for the presence of GCK gene mutations including the missense mutations at position Thr228Ala in exon 7, Gly299Arg in exon 8 and nonsense mutation Ser383Ter in exon 9, utilizing polymerase chain reaction with restriction fragment length polymorphism (PCR-RFLP) analysis. The results shows no Thr228Ala, Gly299Arg and Ser383Ter mutations were detected in both groups, which was differ from the results obtained for Italian and Caucasian from the Oxford region in UK MODY2 patients. Our data indicated that the previously studied mutations in Italian and Caucasian patients in the GCK gene are not common in MODY Jordanian population, suggesting a racial difference can be found in the frequency of the GCK polymorphism.
引用
收藏
页码:343 / 347
页数:4
相关论文
共 50 条
  • [21] INTRODUCING GLUCOKINASE DEFICIENCY INTO MICE, AN ANIMAL-MODEL FOR MATURITY-ONSET DIABETES OF THE YOUNG (MODY)
    GRUPE, A
    HULTGREN, B
    STEWART, TA
    DIABETES, 1995, 44 : A18 - A18
  • [22] Diagnosis and Treatment of Maturity-Onset Diabetes of the Young (MODY)
    Emmelheinz, Markus
    Knebel, Birgit
    Muessig, Karsten
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 (05) : 378 - 389
  • [23] CLINICAL INVESTIGATIONS IN MATURITY-ONSET DIABETES OF THE YOUNG (MODY)
    HALMOS, T
    SUBA, I
    KAUTZKY, L
    DIABETOLOGIA, 1982, 23 (02) : 172 - 172
  • [24] Using FRET to study maturity-onset diabetes of the young type 2 (MODY-2)-associated glucokinase mutations in living beta cells
    Ding, Shi-Ying
    He, Li-Ping
    Rizzo, Mark A.
    DIABETES, 2006, 55 : A374 - A374
  • [25] Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY)
    Diren, Ayca
    Demirci, Deniz Kanca
    Gul, Nurdan
    Karacanli, Burcin
    Baykut, Aykut
    Tutuncu, Yildiz
    Ozturk, Oguz
    Satman, Ilhan
    Yilmaz-aydogan, Hulya
    IN VIVO, 2022, 36 (05): : 2490 - 2504
  • [26] Maturity-onset diabetes of the young (MODY): the history of its dismemberment
    Froguel, P
    ANNALES D ENDOCRINOLOGIE, 2003, 64 (03) : S12 - S16
  • [27] Maturity-onset diabetes of the young (MODY): Genetic and clinical characteristics
    Velho, G
    Robert, JJ
    HORMONE RESEARCH, 2002, 57 : 29 - 33
  • [28] Update on clinical screening of maturity-onset diabetes of the young (MODY)
    Peixoto-Barbosa, Renata
    Reis, Andre F.
    Giuffrida, Fernando M. A.
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01):
  • [29] Predictive genetic testing in maturity-onset diabetes of the young (MODY)
    Shepherd, M
    Ellis, I
    Ahmad, AM
    Todd, PJ
    Bowen-Jones, D
    Mannion, G
    Ellard, S
    Sparkes, AC
    Hattersley, AT
    DIABETIC MEDICINE, 2001, 18 (05) : 417 - 421
  • [30] Update on clinical screening of maturity-onset diabetes of the young (MODY)
    Renata Peixoto-Barbosa
    André F. Reis
    Fernando M. A. Giuffrida
    Diabetology & Metabolic Syndrome, 12